Mycenax Biotech Inc.


Please enter the company code as 4726 Go to Link

Mycenax on BIO International Convention 2018


Mycenax business development team is going to attend BIO International Convention on the 4th to the 7th of June 2018 in Boston.
As a CMC-specialized biotech, Mycenax provides the comprehensive and integrated services to our customers; from process development, formulation development, analytical methods development and qualification, protein characterization to clinical and commercial scale cGMP manufacturing, and regulatory document preparation. Moreover, we are eager to promote our self-developed biological drug TuNEX® and LusiNEX, a biosimilar drug, to find partners for overseas sales, marketing, and joint development with this exhibition!
BIO International Convention is the world's largest biotechnology exhibition that attracts over 100 major global pharmaceutical companies each year. Biotechnology companies and academic institutions participated in the exhibition will publish the latest technology through this exhibition, and fascinate countless professionals in the biotechnology field.